Acute lymphoblastic leukaemia: open trials in Austria

15 open trials have a site in Austria. Registry data; only the trial team decides who can take part.

NCT07899840
Establishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
Research · Fondazione Matilde Tettamanti Menotti De Marchi Onlus
Saint Anna Kinderspital, Vienna
Registry updated 2026-10-28
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-10-26
NCT07297914
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
Trial Treatment · Phase 2/3 · Bambino Gesù Hospital and Research Institute
St'Anna Children Hospital, Vienna
Registry updated 2026-10-20
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna · St. Anna Childrens Cancer Research Institute GmbH, Vienna
Registry updated 2026-10-19
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-09-24
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-09-04
NCT02872987
GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
Research · Goethe University
Universitätsklinikum Graz, Graz · LKH Hochsteiermark-Leoben, Leoben · Ordensklinikum Linz Elisabethinen, Linz · Universitätsklinikum St. Pölten, Sankt Pölten · Hanusch-Krankenhaus Wien, Vienna
Registry updated 2026-08-05
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Medical University of Graz, Graz · Ordensklinikum Linz GmbH, Linz · Hanusch Krankenhaus der Wiener Gebietskrankenkasse, Vienna
Registry updated 2026-07-06
2023-504694-20-00
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-06-04
2025-520982-39-00
Study on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
Trial Treatment · Phase 3 · Universita Degli Studi Di Milano Bicocca
Universitatsklinik für Innere Medizin Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Eb Haus Austria Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-05-08
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Kepler Universitaetsklinikum GmbH, Linz · Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2026-03-17
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
St. Anna Kinderspital GmbH, Vienna
Registry updated 2025-09-16
NCT05745714
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
St. Anna Kinderspital GmbH, Vienna
Registry updated 2025-09-16
NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
St. Anna Kinderspital GmbH, Vienna
Registry updated 2025-09-16
NCT03643276
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Trial Treatment · Phase 3 · Martin Schrappe
Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Kepler Universitaetsklinikum GmbH, Linz · Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH, Salzburg · St. Anna Kinderspital GmbH, Vienna
Registry updated 2025-04-06

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error